Matthieu Mahévas

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia

Vivek Patel, Matthieu Mahévas, Soo Yong Lee et al. · Blood · 2012 · 344 citations · Full text

Medicine, Hematology, Immunology +7

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

Léa Hoisnard, Bénédicte Lebrun‐Vignes, Sébastien Maury et al. · Scientific Reports · 2022 · 171 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single‐center experience with 60 patients

Mathilde Roumier, Valentine Loustau, Constance Guillaud et al. · American Journal of Hematology · 2014 · 151 citations · Full text

Life Sciences, Hematology, Immunology +17

The temporary use of thrombopoietin‐receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study

Matthieu Mahévas, Olivier Fain, Mikaël Ebbo et al. · British Journal of Haematology · 2014 · 128 citations

Life Sciences, Hematology, Pharmacotherapy +13

Long-term complications of splenectomy in adult immune thrombocytopenia

Lan-Huong Thai, Matthieu Mahévas, Françoise Roudot‐Thoraval et al. · Medicine · 2016 · 86 citations · Full text

Medicine, Hematology, Surgery +15